| Serial Number | 87278812 |
| Word Mark | T TITAN PHARMACEUTICALS |
| Filing Date | Thursday, December 22, 2016 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 18, 2019 |
| Registration Number | 5782129 |
| Registration Date | Tuesday, June 18, 2019 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 28, 2018 |
| Description of Mark | The mark consists of the stylized wording "TITAN PHARMACEUTICALS" in black adjacent to a design comprising a stylized letter "T" with the left half in color red, a triangle in color red with a dot in the middle in color white and the rest of the letter "T" in color white. |
| Goods and Services | Pharmaceuticals, namely, treatment for central nervous disorders, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; implantable delivery systems comprised of sustainable release drugs for treatment for central nervous disorders and other serious and life-threatening diseases, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases |
| Indication of Colors claimed | The color(s) red, black and white is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "PHARMACEUTICALS" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 6, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, February 26, 2019 |
| First Use In Commerce Date | Tuesday, February 26, 2019 |
| Party Name | Titan Pharmaceuticals, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Party Name | Titan Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Party Name | Titan Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Event Date | Event Description |
| Tuesday, December 27, 2016 | NEW APPLICATION ENTERED |
| Friday, January 6, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, January 7, 2017 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Sunday, January 8, 2017 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Friday, September 15, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, January 8, 2017 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
| Wednesday, March 22, 2017 | ASSIGNED TO EXAMINER |
| Wednesday, March 29, 2017 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 29, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, March 29, 2017 | NON-FINAL ACTION E-MAILED |
| Friday, September 15, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, October 9, 2017 | SUSPENSION LETTER WRITTEN |
| Friday, September 15, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, July 25, 2018 | EXAMINER'S AMENDMENT ENTERED |
| Monday, October 9, 2017 | LETTER OF SUSPENSION E-MAILED |
| Monday, October 9, 2017 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, March 28, 2018 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Friday, April 13, 2018 | ASSIGNED TO LIE |
| Tuesday, April 17, 2018 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Wednesday, July 25, 2018 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, July 25, 2018 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, July 25, 2018 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, July 25, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 8, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 28, 2018 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 28, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 23, 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, April 17, 2019 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, April 17, 2019 | SOU EXTENSION 1 FILED |
| Wednesday, April 17, 2019 | SOU EXTENSION 1 GRANTED |
| Tuesday, April 23, 2019 | TEAS STATEMENT OF USE RECEIVED |
| Friday, April 19, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, April 23, 2019 | USE AMENDMENT FILED |
| Sunday, May 5, 2019 | STATEMENT OF USE PROCESSING COMPLETE |
| Sunday, May 5, 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, May 17, 2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, June 18, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 18, 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Thursday, May 16, 2019 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |